Table of Contents
Journal of Allergy
Volume 2013, Article ID 260518, 5 pages
http://dx.doi.org/10.1155/2013/260518
Review Article

Roles of IL-22 in Allergic Airway Inflammation

Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba City, Chiba 260-8670, Japan

Received 4 October 2012; Revised 21 January 2013; Accepted 22 January 2013

Academic Editor: Antoon J. M. van Oosterhout

Copyright © 2013 Koichi Hirose et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Eder, M. J. Ege, and E. Von Mutius, “The asthma epidemic,” The New England Journal of Medicine, vol. 355, no. 21, pp. 2226–2235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. T. Holgate, “Innate and adaptive immune responses in asthma,” Nature Medicine, vol. 18, pp. 673–683, 2012. View at Google Scholar
  3. D. T. Umetsu, J. J. McIntire, O. Akbari, C. Macaubas, and R. H. Dekruyff, “Asthma: an epidemic of dysregulated immunity,” Nature Immunology, vol. 3, no. 8, pp. 715–720, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Chakir, J. Shannon, S. Molet et al., “Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression,” Journal of Allergy and Clinical Immunology, vol. 111, no. 6, pp. 1293–1298, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Molet, Q. Hamid, F. Davoine et al., “IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines,” Journal of Allergy and Clinical Immunology, vol. 108, no. 3, pp. 430–438, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Wakashin, K. Hirose, Y. Maezawa et al., “IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 10, pp. 1023–1032, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. X. O. Yang, H. C. Seon, H. Park et al., “Regulation of inflammatory responses by IL-17F,” Journal of Experimental Medicine, vol. 205, no. 5, pp. 1063–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Lajoie, I. P. Lewkowich, Y. Suzuki et al., “Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma,” Nature Immunology, vol. 11, no. 10, pp. 928–935, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Schnyder, C. Lima, and S. Schnyder-Candrian, “Interleukin-22 is a negative regulator of the allergic response,” Cytokine, vol. 50, no. 2, pp. 220–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Farfariello, C. Amantini, M. Nabissi et al., “IL-22 mRNA in peripheral blood mononuclear cells from allergic rhinitic and asthmatic pediatric patients,” Pediatric Allergy and Immunology, vol. 22, no. 4, pp. 419–423, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Zhu, Y. Cao, K. Li et al., “Increased expression of aryl hydrocarbon receptor and interleukin 22 in patients with allergic asthma,” Asian Pacific Journal of Allergy and Immunology, vol. 29, pp. 266–272, 2011. View at Google Scholar
  12. Y. Zhao, J. Yang, Y. D. Gao, and W. Guo, “Th17 immunity in patients with allergic asthma,” International Archives of Allergy and Immunology, vol. 151, no. 4, pp. 297–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Dumoutier, J. Louahed, and J. C. Renauld, “Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9,” Journal of Immunology, vol. 164, no. 4, pp. 1814–1819, 2000. View at Google Scholar · View at Scopus
  14. G. F. Sonnenberg, L. A. Fouser, and D. Artis, “Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces,” Advances in Immunology, vol. 107, pp. 1–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Wolk and R. Sabat, “Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells,” Cytokine and Growth Factor Reviews, vol. 17, no. 5, pp. 367–380, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Lejeune, L. Dumoutier, S. Constantinescu, W. Kruijer, J. J. Schuringa, and J. C. Renauld, “Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line: pathways that are shared with and distinct from IL-10,” Journal of Biological Chemistry, vol. 277, no. 37, pp. 33676–33682, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Pickert, C. Neufert, M. Leppkes et al., “STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing,” Journal of Experimental Medicine, vol. 206, no. 7, pp. 1465–1472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. F. Pan, X. P. Li, S. G. Zheng, and D. Q. Ye, “Emerging role of interleukin-22 in autoimmune diseases,” Cytokine and Growth Factor Reviews. In press.
  19. Y. Zheng, D. M. Danilenko, P. Valdez et al., “Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis,” Nature, vol. 445, no. 7128, pp. 648–651, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. L. A. Zenewicz, G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, M. Karow, and R. A. Flavell, “Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation,” Immunity, vol. 27, no. 4, pp. 647–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. L. A. Zenewicz, G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, S. Stevens, and R. A. Flavell, “Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease,” Immunity, vol. 29, no. 6, pp. 947–957, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Takahashi, K. Hirose, S. Kawashima et al., “IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation,” Journal of Allergy and Clinical Immunology, vol. 128, pp. 1067–1076, 2011. View at Google Scholar
  23. C. Taube, C. Tertilt, G. Gyulveszi et al., “IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease,” PLoS ONE, vol. 6, Article ID e21799, 2011. View at Google Scholar
  24. A. G. Besnard, R. Sabat, L. Dumoutier et al., “Dual role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A,” American Journal of Respiratory and Critical Care Medicine, vol. 183, pp. 1153–1163, 2011. View at Google Scholar
  25. K. Nakagome, M. Imamura, K. Kawahata et al., “High expression of IL-22 suppresses antigen-induced immune responses and eosinophilic airway inflammation via an IL-10-associated mechanism,” Journal of Immunology, vol. 187, pp. 5077–5089, 2011. View at Google Scholar
  26. F. C. Van Reijsen, C. A. F. M. Bruijnzeel-Koomen, F. S. Kalthoff et al., “Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis,” Journal of Allergy and Clinical Immunology, vol. 90, no. 2, pp. 184–193, 1992. View at Google Scholar · View at Scopus
  27. J. M. Spergel, “From atopic dermatitis to asthma: the atopic march,” Annals of Allergy, Asthma and Immunology, vol. 105, no. 2, pp. 99–106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Dumoutier, D. Lejeune, D. Colau, and J. C. Renauld, “Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22,” Journal of Immunology, vol. 166, no. 12, pp. 7090–7095, 2001. View at Google Scholar · View at Scopus
  29. S. Huber, N. Gagliani, L. A. Zenewicz et al., “IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine,” Nature, vol. 491, pp. 259–263, 2012. View at Google Scholar
  30. M. Cella, A. Fuchs, W. Vermi et al., “A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity,” Nature, vol. 457, no. 7230, pp. 722–725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Duhen, R. Geiger, D. Jarrossay, A. Lanzavecchia, and F. Sallusto, “Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells,” Nature Immunology, vol. 10, no. 8, pp. 857–863, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. C. Liang, X. Y. Tan, D. P. Luxenberg et al., “Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides,” Journal of Experimental Medicine, vol. 203, no. 10, pp. 2271–2279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Takatori, Y. Kanno, W. T. Watford et al., “Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22,” Journal of Experimental Medicine, vol. 206, no. 1, pp. 35–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Wolk, S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat, “IL-22 increases the innate immunity of tissues,” Immunity, vol. 21, no. 2, pp. 241–254, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Basu, D. B. O’Quinn, D. J. Silberger et al., “Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria,” Immunity, vol. 37, pp. 1061–1075, 2012. View at Google Scholar
  36. B. N. Lambrecht and H. Hammad, “The airway epithelium in asthma,” Nature Medicine, vol. 18, pp. 684–692, 2012. View at Google Scholar
  37. A. P. Moreira, K. A. Cavassani, U. B. Ismailoglu et al., “The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A,” The Journal of Clinical Investigation, vol. 121, pp. 4420–4432, 2011. View at Google Scholar
  38. A. M. Hanash, J. A. Dudakov, G. Hua et al., “Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease,” Immunity, vol. 37, pp. 339–350, 2012. View at Google Scholar
  39. E. J. Swindle, J. E. Collins, and D. E. Davies, “Breakdown in epithelial barrier function in patients with asthma: identification of novel therapeutic approaches,” Journal of Allergy and Clinical Immunology, vol. 124, no. 1, pp. 23–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Xiao, S. M. Puddicombe, S. Field et al., “Defective epithelial barrier function in asthma,” Journal of Allergy and Clinical Immunology, vol. 128, pp. 549–556, 2011. View at Google Scholar
  41. L. Cosmi, L. Maggi, V. Santarlasci et al., “Identification of a novel subset of human circulating memory CD4+ T cells that produce both IL-17A and IL-4,” Journal of Allergy and Clinical Immunology, vol. 125, no. 1–3, pp. 222.e4–230.e4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Pennino, P. K. Bhavsar, R. Effner et al., “IL-22 suppresses IFN-g-mediated lung inflammation in asthmatic patients,” Journal of Allergy and Clinical Immunology. In press.
  43. Y. Chang, L. Al-Alwan, P. A. Risse et al., “TH17 cytokines induce human airway smooth muscle cell migration,” Journal of Allergy and Clinical Immunology, vol. 127, no. 4, pp. 1046.e2–1053.e2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Kudo, A. C. Melton, C. Chen et al., “IL-17A produced by ab T cells drive airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction,” Nature Medicine, vol. 18, pp. 547–554, 2012. View at Google Scholar
  45. Y. Chang, L. Al-Alwan, P. A. Risse et al., “Th17-associated cytokines promote human airway smooth muscle cell proliferation,” The FASEB Journal, vol. 26, pp. 5152–5160, 2012. View at Google Scholar